HomeAI · summaries
Storia in 6 fonti
Prostate cancer breakthrough as drug combo gives patients a powerful new chance
Data from a late-stage trial, presented on Sunday, indicate that the treatment, administered six months before and after surgery, substantially increased the chances of eliminating cancer and reduced the risk of disease progression or death
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
ASCO: J&J breaks the prostate cancer treatment mold with fresh Erleada ph. 3 win
With a new phase 3 win for Erleada (apalutamide), Johnson & Johnson is proposing a solution to a longstanding prostate cancer treatment gap. | In its 2,000-patient Proteus study,…
- ·
statnews.com
For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds
By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.
